Stocktoria
ALNYLAM PHARMACEUTICALS, INC. ALNY
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2004-05-28
ALNYLAM PHARMACEUTICALS, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| PYOTT DAVID E I | director | 2026-06-01 | Option exercise | 3,830 | — |
| PYOTT DAVID E I | director | 2026-06-01 | Sell | 921 | $297.71 |
| PYOTT DAVID E I | director | 2026-06-01 | Sell | 1,175 | $298.91 |
| PYOTT DAVID E I | director | 2026-06-01 | Sell | 1,222 | $299.87 |
| PYOTT DAVID E I | director | 2026-06-01 | Sell | 495 | $300.72 |
| PYOTT DAVID E I | director | 2026-06-01 | Sell | 17 | $302.65 |
| Sigal Charles Elliott | director | 2026-05-20 | Grant | 671 | — |
| SCHULMAN AMY W | director | 2026-05-20 | Grant | 838 | — |
Source: SEC EDGAR filings · CIK 0001178670 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.